查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1702349

全球醫療保健市場眼動追蹤：2025-2033

Global Eye Tracking in Healthcare Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球醫療保健眼動追蹤市場規模達到 8.0287 億美元，預計到 2033 年將達到 51.5583 億美元，在 2025-2033 年預測期內的複合年成長率為 21.4%。

全球醫療保健市場中的眼動追蹤利用眼動追蹤技術來增強醫療保健服務的各個方面，從診斷工具到改善醫療設備和應用程式的使用者體驗。眼動追蹤可以測量人的眼睛的運動和焦點，為神經評估、認知障礙診斷和復健治療提供寶貴的資料。

此技術用於監測眼球運動，以檢測中風、失智症和視力障礙等疾病，同時也能深入了解注意力不足過動症或自閉症等精神健康狀況。透過追蹤患者的關注和關注方式，醫療保健專業人員可以更深入地了解認知和神經健康，從而實現更精確的治療和診斷。

市場動態：

駕駛員和約束裝置

神經系統疾病和認知障礙盛行率上升

神經和認知障礙盛行率的上升是全球醫療保健市場眼動追蹤技術發展的關鍵促進因素。隨著阿茲海默症、帕金森氏症、中風和自閉症譜系障礙 (ASD) 等神經和認知疾病變得越來越普遍，對眼動追蹤技術等創新診斷和監測工具的需求也在增加。

眼動追蹤透過分析眼球運動為這些疾病提供了寶貴的見解，有助於識別早期跡象並有助於更準確的診斷。例如，世界衛生組織估計，全球約有 5,000 萬人患有失智症，預計到 2030 年這一數字將上升到 8,200 萬人。此外，帕金森氏症影響著全球約 1,000 萬人。這些數字強調了醫療保健領域對更好的診斷工具的迫切需求。

眼動追蹤技術在評估神經功能、檢測認知的早期變化以及提供一種非侵入性的方式來監測病情隨時間的發展方面可以發揮關鍵作用。隨著全球人口老化和認知障礙發病率的增加，眼動追蹤技術正成為臨床醫師改善病患照護和提高治療效果的重要工具。所有這些因素都要求醫療保健市場進行全球眼動追蹤。

設備和實施成本高昂

設備和實施的高成本對全球醫療保健市場中的眼動追蹤技術造成了重大限制，限制了該技術的廣泛應用，尤其是在醫療保健領域。眼動追蹤系統，特別是那些為醫療診斷或神經評估而設計的系統，通常涉及高階感測器、專用軟體和先進的硬體組件，價格昂貴。

例如，能夠檢測與神經系統疾病或認知障礙相關的細微眼球運動的臨床級系統需要在設備和支援基礎設施方面進行大量投資。眼動追蹤系統的價格範圍為 1.001 美元至 10,000 美元，這可能會對全球醫療保健市場眼動追蹤的發展造成限制，因為這些系統雖然適用於某些應用，但可能無法滿足更先進的醫療保健診斷所需的精度和可靠性標準。因此，上述因素可能會限制全球醫療保健市場眼動追蹤的潛在成長。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 按追蹤類型分類的程式碼片段
  • 按組件截取片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • 神經系統疾病和認知障礙盛行率上升
      • 眼動追蹤技術的進步
    • 限制
      • 設備和實施成本高昂
      • 隱私和資料安全問題
    • 機會
      • 與虛擬實境 (VR) 和擴增實境 (AR) 的整合
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章：醫療保健市場中的眼動追蹤（按類型）

  • 眼電圖（EOG）
    • 追蹤
  • 光學追蹤
  • 眼動追蹤

第6章：醫療保健市場中的眼動追蹤（按追蹤類型）

  • 遠端追蹤
  • 行動追蹤

第7章：醫療保健市場中的眼動追蹤（按組件分類）

  • 硬體
  • 軟體

第 8 章：醫療市場中的眼動追蹤（按應用）

  • 醫學研究與診斷
  • 輔助技術
  • 認知與神經學研究
  • 眼科與視覺科學

第9章：醫療市場中的眼動追蹤（按最終用戶）

  • 醫療保健提供者
  • 研究機構
  • 輔助設備製造商

第10章：醫療保健市場中的眼動追蹤，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第12章：公司簡介

  • Tobii
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • SR Research Ltd.
  • iMotions
  • Gazepoint
  • EyeTech Digital Systems, Inc.
  • Pupil Labs GmbH.
  • EyeTracking
  • Smart Eye
  • Lumen
  • ERGONEERS GmbH

第13章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 14 章：附錄

簡介目錄
Product Code: MD9433

The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.

The global eye tracking in healthcare market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person's eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.

This technology is used to monitor eye movements for the detection of conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. By tracking where and how patients focus, healthcare professionals gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurological and Cognitive Disorders

The rising prevalence of neurological and cognitive disorders is a key driver in the global eye tracking in healthcare market. As neurological and cognitive conditions such as Alzheimer's disease, Parkinson's disease, stroke, and autism spectrum disorders (ASD) become more common, the demand for innovative diagnostic and monitoring tools, such as eye tracking technology, is increasing.

Eye tracking offers valuable insights into these disorders by analyzing eye movements, helping to identify early signs and aiding in more accurate diagnoses. For instance, the World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, and the number is expected to rise to 82 million by 2030. Additionally, Parkinson's disease affects about 10 million people globally. These numbers underscore the urgent need for better diagnostic tools in the healthcare sector.

Eye tracking can play a critical role in assessing neurological function, detecting early changes in cognition, and offering a non-invasive way to monitor disease progression over time. As the global population ages and the incidence of cognitive disorders increases, eye tracking technology is becoming an essential tool for clinicians aiming to improve patient care and enhance treatment outcomes. All these factors demand global eye tracking in the healthcare market.

High Costs of Equipment and Implementation

The high costs of equipment and implementation pose a significant restraint in the global eye tracking in healthcare market, limiting the widespread adoption of this technology, especially in healthcare settings. Eye tracking systems, particularly those designed for medical diagnostics or neurological assessments, often involve high-end sensors, specialized software, and advanced hardware components that come at a steep price.

For instance, clinical-grade systems capable of detecting subtle eye movements associated with neurological diseases or cognitive disorders require significant investment in both equipment and the infrastructure to support them. The price range of $1.001 to $10,000 for eye tracking systems can act as a restraint in the global eye tracking in healthcare market because these systems, while suitable for certain applications, may not meet the precision and reliability standards required for more advanced healthcare diagnostics. Thus, the above factors could be limiting the global eye tracking in the healthcare market's potential growth.

Segment Analysis

The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.

Tracking Type:

The remote tracking segment in tracking type is expected to dominate the global eye tracking in healthcare market with the highest market share

The remote tracking segment of the global eye tracking in healthcare market leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.

This capability is crucial in telemedicine platforms, mobile health apps, and home-based monitoring systems. By allowing healthcare providers to track patients from a distance, remote eye tracking can be especially beneficial for continuous monitoring of those with neurological conditions, cognitive disorders, or individuals undergoing rehabilitation therapies.

It eliminates the need for patients to visit healthcare facilities regularly, improving access to care and enhancing patient convenience. This is especially important as patients, particularly those with chronic conditions, can experience fluctuations in symptoms that require consistent tracking.

By enabling eye movement analysis outside of medical environments, remote tracking technology offers greater flexibility in patient care and supports early detection of changes in cognitive or neurological health. It also allows for real-time data collection, making it easier to adjust treatment plans or interventions based on immediate insights. These factors have solidified the segment's position in the global eye tracking in healthcare market.

Geographical Analysis

North America is expected to hold a significant position in the global eye tracking in healthcare market, with the highest market share

The North American eye tracking in healthcare market is being driven by several factors. One of the key drivers is the increasing application of eye tracking technology in the healthcare sector, particularly for diagnosing and monitoring neurological disorders like Parkinson's disease, Alzheimer's, and other cognitive impairments. This technology provides valuable insights into eye movements and gaze patterns, which help in early detection and assessment, enhancing the effectiveness of treatment and rehabilitation.

Furthermore, North America's advanced healthcare system and technological infrastructure play a significant role in driving the market. The region is home to leading research institutions and healthcare providers that integrate eye tracking into clinical practices, such as in cognitive rehabilitation and assistive devices for patients with severe motor disabilities.

The region is also seeing increased adoption in consumer electronics, gaming, and the automotive industry, all of which are contributing to the broader use of eye tracking in healthcare settings. Thus, the above factors are consolidating the region's position as a dominant force in the global eye tracking in healthcare market.

Competitive Landscape

The major global players in the eye tracking in healthcare market include Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, and ERGONEERS GmbH, among others.

Key Developments

  • In February 2024, Visage Imaging, Inc. unveiled the innovative Visage Ease VP for Apple Vision Pro, Apple's much-awaited spatial computing platform. Tailored to leverage the distinct features of Apple Vision Pro, Visage Ease VP enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
  • In January 2024, Tobii's launch of the UX Explore cloud platform, designed to enhance mobile user experience (UX) research with eye-tracking technology, is a significant development that could positively impact the global eye-tracking in healthcare market. This cloud-based solution allows for more scalable, efficient, and accessible UX research, enabling healthcare professionals and developers to evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices with greater ease.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global eye tracking in healthcare market report delivers a detailed analysis with 78 key tables, more than 71 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Tracking Type
  • 2.5. Snippet by Component
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Neurological and Cognitive Disorders
      • 3.1.1.2. Advancements in Eye Tracking Technology
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Equipment and Implementation
      • 3.1.2.2. Privacy and Data Security Concerns
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration with Virtual Reality (VR) and Augmented Reality (AR)
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Eye Tracking in Healthcare Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Electrooculography (EOG)*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Tracking
  • 5.3. Optical Tracking
  • 5.4. Eye-Attached Tracking

6. Eye Tracking in Healthcare Market, By Tracking Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 6.1.2. Market Attractiveness Index, By Tracking Type
  • 6.2. Remote Tracking*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mobile Tracking

7. Eye Tracking in Healthcare Market, By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Hardware*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Software

8. Eye Tracking in Healthcare Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Medical Research & Diagnostics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Assistive Technology
  • 8.4. Cognitive & Neurological Studies
  • 8.5. Ophthalmology & Vision Science

9. Eye Tracking in Healthcare Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Research Institutes
  • 9.4. Assistive Device Manufacturers

10. Eye Tracking in Healthcare Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Tobii*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. SR Research Ltd.
  • 12.3. iMotions
  • 12.4. Gazepoint
  • 12.5. EyeTech Digital Systems, Inc.
  • 12.6. Pupil Labs GmbH.
  • 12.7. EyeTracking
  • 12.8. Smart Eye
  • 12.9. Lumen
  • 12.10. ERGONEERS GmbH

LIST NOT EXHAUSTIVE

13. Assumptions and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us